Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans

L. Aspinall, Sherrie; B. Good, C.; Zhao, Xinhua; E. Cunningham, Francesca; B Heron, Bernadette; Geraci, M.; A Passero, Vida; Stone, R.; J Smith, Kenneth; Rogers, R.; Shields, Jenna; Sartore, M.; Boyle, D.; Giberti, Sherry; Szymanski, J.; H. Smith, Douglas; Ha, Allen; Sessions, J.; Depcinski, Shawn; Fishco, Shane; Molina, I.; Lepir, Tanja; Jean, Carmela; Cruz-Diaz, Lymaris; Motta, Jessica; Calderon-Vargas, Rebeca; Maland, Jane; Keefe, S.; Tague, M.; Leone, A.; Glovack, Brian; Kaplan, B.; Cosgriff, Sean; Kaster, Lindsay; Tonnu-Mihara, I.; Nguyen, K.; Carmichael, J.; Clifford, L.; Lu, K.; Chatta, G.

doi:10.1186/s12885-015-1038-y

Public

Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans

Shared by NobleBlocks on Feb 18, 2015 • 12:00 AM UTC

Authors:

Sherrie L. Aspinall

C. B. Good

Xinhua Zhao

Abstract

BackgroundGiven the paucity of information on dose intensity, the objective of this study is to describe the use of adjuvant chemotherapy for stage III colon cancer, focusing on relative dose intensity (RDI), overall survival (OS) and disease-free survival (DFS).MethodsRetrospective cohort of 367 pa...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!